SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-23-000031
Filing Date
2023-11-01
Accepted
2023-11-01 06:03:05
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20230930.htm   iXBRL 10-Q 1833836
2 EX-10.1 uthrex10109302023.htm EX-10.1 21408
3 EX-31.1 uthrex31109302023.htm EX-31.1 11603
4 EX-31.2 uthrex31209302023.htm EX-31.2 11609
5 EX-32.1 uthrex32109302023.htm EX-32.1 6473
6 EX-32.2 uthrex32209302023.htm EX-32.2 6600
  Complete submission text file 0001082554-23-000031.txt   8510386

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20230930.xsd EX-101.SCH 49181
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20230930_cal.xml EX-101.CAL 71783
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20230930_def.xml EX-101.DEF 261914
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20230930_lab.xml EX-101.LAB 739270
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20230930_pre.xml EX-101.PRE 468380
70 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20230930_htm.xml XML 1354725
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 231366402
SIC: 2834 Pharmaceutical Preparations